Leu-enkephalin inhibited self-stimulation in one reward center but facilitated it when injected into another — showing opioid effects on motivation are region-specific.
Region-specific reward modulationSame peptide inhibited reward in SN-VTA but facilitated it from MFB-LH
What the researchers found
Leu-enkephalin and leu-enkephalinamide inhibited electrical self-stimulation in the substantia nigra/ventral tegmental area (SN-VTA) but not the medial forebrain bundle/lateral hypothalamus (MFB-LH). However, injection into MFB-LH facilitated self-stimulation of the distant SN-VTA.
Ala-leu-enkephalin injected into SN-VTA actually facilitated its self-stimulation (opposite to leu-enkephalin). The same peptide in MFB-LH facilitated SN-VTA stimulation like the other enkephalins.
Dynorphin A(1-13) injected into SN-VTA facilitated its self-stimulation. Injection into MFB-LH had no effect.
Met-enkephalin had no direct or indirect effects in either region.
These differences likely reflect different receptor preferences in the SN-VTA neural organization.
Why it matters
The brain's reward system is central to addiction. Finding that different opioid peptides have opposite effects in different reward centers reveals the complexity of opioid-reward interactions. This matters for understanding opioid addiction and developing treatments.
How the study worked
Rats with electrodes in both SN-VTA and MFB-LH received microinjections of five opioid peptides into one site while recording self-stimulation at both sites. This cross-regional design revealed both direct and remote effects of opioid peptides on reward.
What this study cannot tell us
Tested in rats, not people. Microinjection affects a small area and may not reflect normal opioid release. Only electrical self-stimulation was tested, which is an artificial reward. The receptor types mediating each effect were not definitively identified.
How to read the evidence
Preliminary animal study with self-stimulation paradigm — standard for reward circuit research.
When this study was published
Published in 1988 — mapped opioid peptide effects in brain reward circuits.
The bigger picture
The brain reward system is central to addiction. Understanding how different opioid peptides affect different reward regions is key to understanding substance abuse and developing targeted treatments.
Questions still open
- Which opioid peptide changes drive addiction?
- Could region-specific opioid modulation treat addiction without affecting other reward?
Common questions
What is self-stimulation?
How does this relate to addiction?
Read the original research
Differential effects of opioid peptides administered intracerebrally in loci of self-stimulation reward of lateral hypothalamus and ventral tegmental area--substantia nigra.
NIDA research monograph, 87, 180-91
Citation
Singh, J; Desiraju, T. (1988). Differential effects of opioid peptides administered intracerebrally in loci of self-stimulation reward of lateral hypothalamus and ventral tegmental area--substantia nigra.. NIDA research monograph, 87, 180-91.